Logo image of BLBX

BLACKBOXSTOCKS INC (BLBX) Stock Fundamental Analysis

NASDAQ:BLBX - Nasdaq - US09229E3036 - Common Stock - Currency: USD

3.95  -1.57 (-28.44%)

After market: 4.1483 +0.2 (+5.02%)

Fundamental Rating

1

BLBX gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 285 industry peers in the Software industry. BLBX has a bad profitability rating. Also its financial health evaluation is rather negative. BLBX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

BLBX had negative earnings in the past year.
In the past year BLBX has reported a negative cash flow from operations.
BLBX had negative earnings in each of the past 5 years.
BLBX had negative operating cash flow in 4 of the past 5 years.
BLBX Yearly Net Income VS EBIT VS OCF VS FCFBLBX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -1M -2M -3M -4M -5M

1.2 Ratios

With a Return On Assets value of -32.05%, BLBX is not doing good in the industry: 79.93% of the companies in the same industry are doing better.
BLBX has a Return On Equity of -50.84%. This is in the lower half of the industry: BLBX underperforms 69.53% of its industry peers.
Industry RankSector Rank
ROA -32.05%
ROE -50.84%
ROIC N/A
ROA(3y)-62.21%
ROA(5y)-256.22%
ROE(3y)-109.23%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLBX Yearly ROA, ROE, ROICBLBX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 -1K

1.3 Margins

BLBX's Gross Margin of 46.76% is on the low side compared to the rest of the industry. BLBX is outperformed by 73.84% of its industry peers.
BLBX's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for BLBX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.38%
GM growth 5Y44.94%
BLBX Yearly Profit, Operating, Gross MarginsBLBX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800

More info and screens

2

2. Health

2.1 Basic Checks

BLBX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BLBX has been reduced compared to 1 year ago.
The number of shares outstanding for BLBX has been increased compared to 5 years ago.
BLBX has a better debt/assets ratio than last year.
BLBX Yearly Shares OutstandingBLBX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M
BLBX Yearly Total Debt VS Total AssetsBLBX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

BLBX has an Altman-Z score of -1.05. This is a bad value and indicates that BLBX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.05, BLBX is doing worse than 77.78% of the companies in the same industry.
A Debt/Equity ratio of 0.03 indicates that BLBX is not too dependend on debt financing.
BLBX has a Debt to Equity ratio (0.03) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -1.05
ROIC/WACCN/A
WACC11.15%
BLBX Yearly LT Debt VS Equity VS FCFBLBX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M 6M

2.3 Liquidity

BLBX has a Current Ratio of 0.36. This is a bad value and indicates that BLBX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of BLBX (0.36) is worse than 95.70% of its industry peers.
A Quick Ratio of 0.35 indicates that BLBX may have some problems paying its short term obligations.
BLBX has a worse Quick ratio (0.35) than 95.70% of its industry peers.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.35
BLBX Yearly Current Assets VS Current LiabilitesBLBX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

2

3. Growth

3.1 Past

BLBX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.61%.
The Revenue for BLBX has decreased by -18.73% in the past year. This is quite bad
Measured over the past years, BLBX shows a very strong growth in Revenue. The Revenue has been growing by 35.10% on average per year.
EPS 1Y (TTM)4.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.7%
Revenue 1Y (TTM)-18.73%
Revenue growth 3Y-2.68%
Revenue growth 5Y35.1%
Sales Q2Q%-11.07%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y69.75%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.45%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BLBX Yearly Revenue VS EstimatesBLBX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
BLBX Yearly EPS VS EstimatesBLBX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BLBX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BLBX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BLBX Price Earnings VS Forward Price EarningsBLBX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BLBX Per share dataBLBX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BLBX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLACKBOXSTOCKS INC

NASDAQ:BLBX (1/23/2025, 8:45:57 PM)

After market: 4.1483 +0.2 (+5.02%)

3.95

-1.57 (-28.44%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)N/A N/A
Inst Owners3.24%
Inst Owner Change0%
Ins Owners40.33%
Ins Owner Change0%
Market Cap13.98M
Analysts82.86
Price Target6.12 (54.94%)
Short Float %10.17%
Short Ratio2.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-18.35%
Min Revenue beat(2)-20.61%
Max Revenue beat(2)-16.09%
Revenue beat(4)1
Avg Revenue beat(4)-14.14%
Min Revenue beat(4)-29.26%
Max Revenue beat(4)9.38%
Revenue beat(8)1
Avg Revenue beat(8)-19.14%
Revenue beat(12)2
Avg Revenue beat(12)-16.12%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.06
P/FCF N/A
P/OCF N/A
P/B 2.23
P/tB 2.23
EV/EBITDA N/A
EPS(TTM)-1.45
EYN/A
EPS(NY)-0.44
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0.78
BVpS1.77
TBVpS1.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -32.05%
ROE -50.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.76%
FCFM N/A
ROA(3y)-62.21%
ROA(5y)-256.22%
ROE(3y)-109.23%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.38%
GM growth 5Y44.94%
F-Score3
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 9.54%
Cap/Sales 0.09%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.36
Quick Ratio 0.35
Altman-Z -1.05
F-Score3
WACC11.15%
ROIC/WACCN/A
Cap/Depr(3y)218.67%
Cap/Depr(5y)131.2%
Cap/Sales(3y)0.83%
Cap/Sales(5y)0.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.7%
EPS Next Y69.75%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.73%
Revenue growth 3Y-2.68%
Revenue growth 5Y35.1%
Sales Q2Q%-11.07%
Revenue Next Year6.45%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y35.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year91.84%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y83.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y83.61%
OCF growth 3YN/A
OCF growth 5YN/A